Interactive Medica, the leading Pharma SaaS provider, today launches IM Strategic Selling, a new Software as a Service (SaaS) solution that enables promotional teams, managers and executives to identify, collaborate, plan and manage goals, strategies and activities for current and potential Key Accounts.
The changing healthcare environment that Pharmaceutical companies face today is radically different from years gone by, companies who do not embrace the more collaborative, many to many, selling approach may find themselves left out of the key relationships required to sustain the use of their products. Being able to implement and manage a Key Account Plan is a pre-requisite for any Pharmaceutical company needing to communicate with multiple decision makers and stakeholders within the Health Service.
“Many of the Pharmaceutical companies that Interactive Medica works with are looking at a Key Account Management approach but are put off by how complex it can appear, we felt that we could use our expertise to create a solution that makes this new sales approach far simpler. IM Strategic Selling supports this new complex method of selling by providing a wizard that helps and guides the sales team through this process making it far simpler to identify key actions or issues that need addressing.”
“IM Strategic Selling is platform independent allowing it to be used in conjunction with Pharmaceutical companies existing CRM and sales support applications enabling any Pharmaceutical sales team to benefit from the solution quickly and easily.”
“IM Strategic Selling allows our clients to co-ordinate a key account plan enabling them to orchestrate and allocate company resources as efficiently as possible. Using IM Strategic Selling, our clients’ account teams become focused on the overall opportunity, the relationships and resources required to strategically expand the account.”
“Miller Heiman’s strategic selling model is one example of a business process that IM Strategic Selling is supporting however, we appreciate that every Pharmaceutical company is different and will adopt the specific model that fits their strategy. With IM Strategic Selling clients will be able to tailor the application to meet their exact business processes. ”
“We are very excited by IM Strategic Selling and the possibilities it can present to Pharmaceutical companies. ” comments Richard Jenkinson, CEO of Interactive Medica.
